EUVIMEDEUVIMED entdecken
Crossref

Engineering a Yeast Cell Factory to Sustainably Biosynthesize Parthenolide

Wenping Wei, Chengshuai Yang iD, Zhen Su, Yan Wang, Pingping Wang iD, Xing Yan, Zhihua Zhou iD

ACS Synthetic Biology · 2025

DOI: 10.1021/acssynbio.4c00665 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Synthetic Biology, 2025. Verfasst von Wenping Wei und 6 weiteren Autor:innen. Beteiligte Einrichtung: CAS-Key Laboratory of Synthetic Biology, CAS Center for Excellence in Molecular Plant Sciences, Chinese Academy of Sciences, Shanghai 200032, China. Hauptthemen laut MEDLINE: Sesquiterpenes, Metabolic Engineering, Saccharomyces cerevisiae. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 57 Literaturangaben. Gefördert von: National Key Laboratory of Plant Molecular Genetics, National Key Research and Development Program of China, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The sesquiterpene lactone parthenolide is a promising anticancer drug. Its biosynthesis via a microbial cell factory has been considered as a sustainable alternative to plant extraction. Herein, systematic metabolic engineering approaches, as well as the introduction of a novel noncanonical tricarboxylic acid (TCA) cycle, were employed to enhance the production of the key precursor germacrene A. By identifying two new dehydrogenases and controlling the expression of parthenolide synthase, we further achieved the elimination of byproducts and enhanced parthenolide production. A two-stage fermentation approach and in situ product extraction using macroreticular resin were further applied to relieve the nocuous effect of costunolide and parthenolide on the growth of yeast cell factories, ultimately achieving a titer of 549.7 mg/L for parthenolide and 972.7 mg/L for costunolide in a 10 L fermenter, which represents the highest reported titer obtained by microbial fermentation. The strategies should also contribute to the microbial cell factory-construction for other natural products exhibiting toxicity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SesquiterpenesMetabolic EngineeringSaccharomyces cerevisiaeFermentationCitric Acid CycleLactones

Stichwörter der Autor:innen

Parthenolidebiosynthesisdynamic regulationmicrobial cell factorytwo-stage fermentation, dehydrogenases

Substanzen

SesquiterpenesparthenolidecostunolideLactones

Autor:innen und Institutionen

  • CAS-Key Laboratory of Synthetic Biology, CAS Center for Excellence in Molecular Plant Sciences, Chinese Academy of Sciences, Shanghai 200032, China.
  • University of Chinese Academy of Sciences, Beijing 100049, China.

ORCID-Profile: Chengshuai Yang, Pingping Wang, Zhihua Zhou

Förderung

  • National Key Laboratory of Plant Molecular Genetics
  • National Key Research and Development Program of China
  • National Natural Science Foundation of China
  • Chinese Academy of Sciences

Zitieren

APA

Wei, W., Yang, C., Su, Z., Wang, Y., Wang, P., Yan, X., & Zhou, Z. (2025). Engineering a Yeast Cell Factory to Sustainably Biosynthesize Parthenolide. ACS Synthetic Biology. https://doi.org/10.1021/acssynbio.4c00665

Vancouver

Wei W, Yang C, Su Z, Wang Y, Wang P, Yan X, et al. Engineering a Yeast Cell Factory to Sustainably Biosynthesize Parthenolide. ACS Synthetic Biology. 2025. doi:10.1021/acssynbio.4c00665

BibTeX
@article{Wei2025,
  author = {Wei, Wenping and Yang, Chengshuai and Su, Zhen and Wang, Yan and Wang, Pingping and Yan, Xing and Zhou, Zhihua},
  title = {Engineering a Yeast Cell Factory to Sustainably Biosynthesize Parthenolide},
  journal = {ACS Synthetic Biology},
  year = {2025},
  doi = {10.1021/acssynbio.4c00665}
}
Kostenlos starten →